The “sugar dilemma”

1Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Type 2 diabetes mellitus is characterized by insulin resistance and elevated blood glucose levels. Treatment protocols generally include dietary restriction of sugar, as well as drugs aiming at a reduction of blood glucose, mainly by activating the insulin system or supplementing insulin. This established approach does not take into account the outstanding physiological role of glucose as a key molecule in metabolism. Glucose is crucial to meet the high energy demand of the brain, which depends on it as an exclusive nutrient. Insulin independent glucose transporters GLUT1 import glucose into the brain. Reduction of blood glucose, as in current treatment concepts, may lead to energy deficiency in the brain and consecutively to worsening of - possibly already impaired - neurocognitive function. Reduced cell membrane fluidity of the vascular endothelium of the blood-brain-barrier (BBB) - due to malnutrition and/or aging - is considered a major factor in pathogenesis of the cerebral metabolic syndrome, which is a key step in neurodegeneration. Under this aspect we suggest a novel approach to prophylaxis and treatment focusing on a sufficient supply of glucose to the brain.

Cite

CITATION STYLE

APA

Noe, C. R., Handschuh, P., Wolfslehner, L., Noe, C. A., Noe-Letschnig, M., Soucek-Noe, D., & Lanzenberger, R. (2020, October 1). The “sugar dilemma.” Pharmazie. Govi-Verlag Pharmazeutischer Verlag GmbH. https://doi.org/10.1691/ph.2020.0684

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free